These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 25889041)

  • 21. Hematopoietic stem cell transplantation for sickle cell disease: state of the science.
    Talano JA; Cairo MS
    Eur J Haematol; 2015 May; 94(5):391-9. PubMed ID: 25200500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of the source of hematopoietic stem cell in unrelated transplants: comparison between 10/10, 9/10-HLA matched donors and cord blood.
    Granier C; Biard L; Masson E; Porcher R; Peffault de Latour R; Robin M; Boissel N; Xhaard A; Ribaud P; Lengline E; Larghero J; Charron D; Loiseau P; Socié G; Dhédin N
    Am J Hematol; 2015 Oct; 90(10):897-903. PubMed ID: 26149659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unrelated cord blood transplantation vs related transplantation with HLA 1-antigen mismatch in the graft-versus-host direction.
    Kanda J; Ichinohe T; Kato S; Uchida N; Terakura S; Fukuda T; Hidaka M; Ueda Y; Kondo T; Taniguchi S; Takahashi S; Nagamura-Inoue T; Tanaka J; Atsuta Y; Miyamura K; Kanda Y;
    Leukemia; 2013 Feb; 27(2):286-94. PubMed ID: 22806066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unrelated allogeneic hematopoietic stem cell transplantation in a patient with Revesz syndrome, a severe variant of dyskeratosis congenita.
    Watanabe K; Arakawa Y; Kambe T; Oguma E; Kishimoto H; Koh K
    Pediatr Blood Cancer; 2019 Jan; 66(1):e27476. PubMed ID: 30259646
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical impact of HLA disparities in transplants from unrelated donors].
    Gallardo D
    Methods Find Exp Clin Pharmacol; 2010 Dec; 32 Suppl A():27-9. PubMed ID: 21381285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical significance of HLA antibodies in hematopoietic stem cell transplantation].
    Yoshihara S; Saji H
    Rinsho Ketsueki; 2012 Apr; 53(4):379-90. PubMed ID: 22687970
    [No Abstract]   [Full Text] [Related]  

  • 27. [Graft source of hematopoietic stem cell transplantation in adult patients with hematologic diseases].
    Takami A
    Rinsho Ketsueki; 2014 Oct; 55(10):2103-12. PubMed ID: 25297777
    [No Abstract]   [Full Text] [Related]  

  • 28. [Selection of stem cell source for allogeneic hematopoietic stem cell transplantation from unrelated donors: focused on comparison between cord blood and bone marrow].
    Atsuta Y
    Rinsho Ketsueki; 2012 Apr; 53(4):396-400. PubMed ID: 22687972
    [No Abstract]   [Full Text] [Related]  

  • 29. The influence of NK alloreactivity on matched unrelated donor and HLA identical sibling haematopoietic stem cell transplantation.
    Witt CS
    Curr Opin Immunol; 2009 Oct; 21(5):531-7. PubMed ID: 19765964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA-haploidentical T cell-depleted allogeneic hematopoietic stem cell transplantation in children with Fanconi anemia.
    Zecca M; Strocchio L; Pagliara D; Comoli P; Bertaina A; Giorgiani G; Perotti C; Corbella F; Brescia L; Locatelli F
    Biol Blood Marrow Transplant; 2014 Apr; 20(4):571-6. PubMed ID: 24462983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selection of unrelated donors for hematopoietic cell transplantation.
    Field T; Anasetti C
    Curr Hematol Rep; 2005 Jul; 4(4):270-5. PubMed ID: 16009041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-HLA antibodies other than against HLA-A, -B, -DRB1 adversely affect engraftment and nonrelapse mortality in HLA-mismatched single cord blood transplantation: possible implications of unrecognized donor-specific antibodies.
    Yamamoto H; Uchida N; Matsuno N; Ota H; Kageyama K; Wada S; Kaji D; Nishida A; Ishiwata K; Takagi S; Tsuji M; Asano-Mori Y; Yamamoto G; Izutsu K; Masuoka K; Wake A; Yoneyama A; Makino S; Taniguchi S
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1634-40. PubMed ID: 24972251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of 28 human embryonic stem cell lines for use as unrelated donors in stem cell therapy: implications of HLA and ABO genotypes.
    Lee JE; Kang MS; Park MH; Shim SH; Yoon TK; Chung HM; Lee DR
    Cell Transplant; 2010; 19(11):1383-95. PubMed ID: 20587141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Significance of confirmatory testing of HLA system in unrelated haematopoietic stem cell donors].
    Dobrovolná M; Vraná M; Brdicka R; Loudová M
    Cas Lek Cesk; 2006; 145(1):32-5. PubMed ID: 16468239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term outcomes of HLA-matched sibling compared with mismatched related and unrelated donor hematopoietic stem cell transplantation for chronic phase chronic myelogenous leukemia: a single institution experience in China.
    Liu QF; Xu XJ; Chen YK; Sun J; Zhang Y; Fan ZP; Xu D; Jiang QL; Wei YQ; Huang F; Feng R; Liu XL; Xu B; Meng FY
    Ann Hematol; 2011 Mar; 90(3):331-41. PubMed ID: 20872002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of HLA matching on hematopoietic cell transplants from unrelated donors.
    Hansen JA; Petersdorf E; Martin PJ; Woolfry A; Anasetti C
    Vox Sang; 2000; 78 Suppl 2():269-71. PubMed ID: 10938967
    [No Abstract]   [Full Text] [Related]  

  • 37. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia.
    Laughlin MJ; Eapen M; Rubinstein P; Wagner JE; Zhang MJ; Champlin RE; Stevens C; Barker JN; Gale RP; Lazarus HM; Marks DI; van Rood JJ; Scaradavou A; Horowitz MM
    N Engl J Med; 2004 Nov; 351(22):2265-75. PubMed ID: 15564543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective recruitment of stem cell donors with rare human leukocyte antigen phenotypes.
    Schmidt AH; Stahr A; Baier D; Schumacher S; Ehninger G; Rutt C
    Bone Marrow Transplant; 2007 Nov; 40(9):823-30. PubMed ID: 17724442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poor outcome with nonmyeloablative conditioning regimen before cord blood transplantation for patients with high-risk acute myeloid leukemia compared with matched related or unrelated donor transplantation.
    Devillier R; Harbi S; Fürst S; Crocchiolo R; El-Cheikh J; Castagna L; Etienne A; Calmels B; Lemarie C; Prebet T; Granata A; Charbonnier A; Rey J; Chabannon C; Faucher C; Vey N; Blaise D
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1560-5. PubMed ID: 24933658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Allogeneic hematopoietic stem cell transplantation from HLA one-locus-mismatched related donors].
    Hyo R; Taguchi J; Kamijo A; Tanaka M; Hashimoto C; Kanamori H; Motomura S; Maruta A; Ishigatsubo Y
    Gan To Kagaku Ryoho; 2009 Nov; 36(11):1845-9. PubMed ID: 19920386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.